The American Journal of Managed Care2d
FDA Approves Mirdametinib for Neurofibromatosis Type 1 With Plexiform Neurofibromas
Adult and pediatric patients with neurofibromatosis type 1 who have symptomatic plexiform neurofibromas that are not amenable ...
Pharm Exec2d
FDA Approves SpringWorks Therapeutics’ Gomekli for Neurofibromatosis Type 1, Symptomatic Plexiform Neurofibromas
Approval makes Gomekli the first treatment to be approved for both adults and pediatric patients for neurofibromatosis type 1 ...
BioSpace9d
Neurofibroma Market Expected to Exhibit a CAGR of 11.5% During 2025-2035, Impelled by Advances in Genetic Research and Precision Medicine
Neurofibroma Market Outlook 2025-2035: The neurofibroma market is demonstrating a promising trajectory, with a projected CAGR of 11.5% across the 7 major markets between 2025 and 2035. A major shift ...
Cuba Headlines8d
U.S. Denies Humanitarian Visa to Cuban Child Damir Due to MINSAP Bureaucracy
The U.S. Embassy in Havana has refused a humanitarian visa for Damir Ortiz Ramírez, a 10-year-old Cuban boy suffering from ...
Cuba Headlines3d
Cuban Woman Holds Solo Protest Outside Havana Hospital for Damir's Health: "This Is Why We Are Where We Are"
A Cuban woman staged a solitary protest outside the "Juan Manuel Márquez" Pediatric Hospital in Havana, demanding medical care for 10-year-old Damir ...
Managed Healthcare Executive7h
FDA Approves Gomekli, First and Only NF1-PN Treatment for Both Children and Adults
Gomekli is the second ever FDA-approved treatment for rare tumor disease, NF1-PN and the first to be approved for both adult and pediatric patients.
GlobalData on MSN2d
FDA approves Gomekli as first neurofibromatosis drug for adults
The US Food and Drug Administration (FDA) has approved SpringWorks Therapeutics’ Gomekli (mirdametinib) to treat ...
UPDATE: SpringWorks Therapeutics Announces FDA Approval of GOMEKLIâ„¢ (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN
GOMEKLI is the first and only medicine approved for both adults and children with NF1-PN –– Approval based on positive data ...
Frontiers12d
Effects of Akt/mTOR/p70S6K Signaling Pathway Regulation on Neuron Remodeling Caused by Translocation Repair
Peripheral nerve injury is a common clinical condition, mainly caused by trauma such as traction, compression, cutting, and ischemia (Huckhagel et al., 2018). Peripheral nerve damage can lead to a ...